ReviewFrontiers in immunology2020

Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities.

Stephen P Hack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.